http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1458012-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_232361c9031a709144573276863c462b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00 |
| filingDate | 1973-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1976-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1458012-A |
| titleOfInvention | Anti-inflammatory steroid |
| abstract | 1458012 Compositions containing 21-adamantoates of corticoids GLAXO LABORATORIES Ltd 3 Jan 1974 [3 Jan 1973 (2)] 448/ 73 and 00036/74 Heading A5B [Also in Division C2] Pharmaceutical and veterinary compositions in dosage unit form containing more than 50 mg but not more than 500 mg of a steroid 21-adamantane-1'-carboxylate of the formula (wherein R is α-CH 3 , #-CH 3 , methylene or, when X and Y are both Cl, α-Cl, X is Cl or F; and Y is #-OH, keto, or when X is Cl, Cl; but when X is F then R is methylene) or the 21-adamantane-1'-carboxylate of prednisolone, hydrocortisone, parametbasone or fluorandrenolone are new. Also new is a method of systemically treating immunological disorders or inflammatory disorders having a significant immunological component which comprises administering within a period of up to 7 days to a non-human animal suffering from such a' disorder an initial dosage of 50-500 mg of one of the aforementioned adamatane carboxylates. The initial dosage m'ay be divided and given on 2 or more days over the 7 dayperiod. Specificatioin 1391443 is referred to. |
| priorityDate | 1973-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.